In Vivo Imaging of the Cannabinoid CB1 Receptor With Positron Emission Tomography

被引：11
|
作者：
Hirvonen, J. [1 ,2 ]
机构：
[1] Turku Univ Hosp, Dept Radiol, FIN-20520 Turku, Finland
[2] Univ Turku, Turku PET Ctr, Turku, Finland
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 97卷 / 06期
关键词：
D O I：
10.1002/cpt.116
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Positron emission tomography (PET) can visualize and quantify receptors and other targets in the living human brain, and recent progress in radioligand development has enabled measurement of cannabinoid type-1 (CB1) receptors. Cannabinoid CB1 receptors have been implicated in multiple human diseases, such as obesity, mood disorders, and addiction. First in vivo human studies have shown distinctive spatial and temporal alterations in cannabinoid CB1 receptor binding in addictive disorders.
引用
收藏
页码：565 / 567
页数：3
相关论文
共 50 条
  • [41] CB1 Cannabinoid Receptor Signaling and Biased Signaling
    Leo, Luciana M.
    Abood, Mary E.
    MOLECULES, 2021, 26 (17):
  • [42] Substituted pyrimidines as cannabinoid CB1 receptor ligands
    Kim, Min Ju
    Kim, Jong Yup
    Seo, Hee Jeong
    Lee, Junwon
    Lee, Sung-Han
    Kim, Mi-Soon
    Kang, Jahyo
    Kim, Jeongmin
    Lee, Jinhwa
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4692 - 4697
  • [43] Cannabinoid CB1 receptor and gastric acid secretion
    Borrelli, Francesca
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (11) : 3102 - 3103
  • [44] Positron Emission Tomography Studies on Cannabinoid Receptor Type 1 in Schizophrenia
    Mihov, Yoan
    BIOLOGICAL PSYCHIATRY, 2016, 79 (12) : E97 - E99
  • [45] Development of Radioligands for In Vivo Imaging of Type 1 Cannabinoid Receptors (CB1) in Human Brain
    Horti, Andrew G.
    Van Laere, Koen
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (31) : 3363 - 3383
  • [46] Crystal Structure of the Human Cannabinoid Receptor CB1
    Hua, Tian
    Vemuri, Kiran
    Pu, Mengchen
    Qu, Lu
    Han, Gye Won
    Wu, Yiran
    Zhao, Suwen
    Shui, Wenqing
    Li, Shanshan
    Korde, Anisha
    Laprairie, Robert B.
    Stahl, Edward L.
    Ho, Jo-Hao
    Zvonok, Nikolai
    Zhou, Han
    Kufareva, Irina
    Wu, Beili
    Zhao, Qiang
    Hanson, Michael A.
    Bohn, Laura M.
    Makriyannis, Alexandros
    Stevens, Raymond C.
    Liu, Zhi-Jie
    CELL, 2016, 167 (03) : 750 - +
  • [47] Cannabinoid CB1 Receptor and Gastric Acid Secretion
    Francesca Borrelli
    Digestive Diseases and Sciences, 2007, 52 : 3102 - 3103
  • [48] Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
    Gardner, Eliot L.
    Bi, Guo-Hua
    Thakur, Ganesh
    Makriyannis, Alexandros
    Seltzman, Herbert H.
    He, Xiang-Hu
    Xi, Zheng-Xiong
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 152 - 152
  • [49] Role of the cannabinoid receptor 1 (CB1) in fear adaptation
    Wotjak, Carsten T.
    ALCOHOL, 2011, 45 (03) : 270 - 270
  • [50] Specific detection of CB1 receptors;: cannabinoid CB1 receptor antibodies are not all created equal!
    Grimsey, Natasha L.
    Goodfellow, Catherine E.
    Scotter, Emma L.
    Dowie, Megan J.
    Glass, Michelle
    Graham, E. Scott
    JOURNAL OF NEUROSCIENCE METHODS, 2008, 171 (01) : 78 - 86
12345